Livia Do Valle Costa

Livia Do Valle Costa

Auto-generated profile, based on publicly available information

Livia Do Valle Costa

Hosp Sirio Libanes, Rua Dona Adma Jafet 91, BR-01308050 Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
KRKalil-Filho Roberto
Kalil-Filho Roberto
RSRoberta Saretta
Roberta Saretta
AFAndré Franci
André Franci
LBLuciano Baracioli
Luciano Baracioli
FGFilomena R. B. G. Galas
Filomena R. B. G. Galas
LDLuciano F. Drager
Luciano F. Drager
Resumo Fundamento A maioria da evidência sobre o impacto da síndrome COVID pós-aguda (PACS, do inglês, post-acute COVID-19 syndrome) descreve sintomas individuais sem correlacioná-los com exames de imagens. Objetivos Avaliar sintomas cardiopulmonares, seus preditores e imagens relacionadas em pacientes com COVID-19 após alta hospitalar. Métodos Pacientes consecutivos, que sobreviveram à COVID-19, foram contatados 90 dias após a alta hospitalar. A equipe de desfechos clínicos (cega quanto aos dados durante a internação) elaborou um questionário estruturado avaliando sintomas e estado clínico. [...] Resumo Fundamento A maioria da evidência sobre o impacto da síndrome COVID pós-aguda (PACS, do inglês, post-acute COVID-19 syndrome) descreve sintomas individuais sem correlacioná-los com exames de imagens. Objetivos Avaliar sintomas cardiopulmonares, seus preditores e imagens relacionadas em pacientes com COVID-19 após alta hospitalar. Métodos Pacientes consecutivos, que sobreviveram à COVID-19, foram contatados 90 dias após a alta hospitalar. A equipe de desfechos clínicos (cega quanto aos dados durante a internação) elaborou um questionário estruturado avaliando sintomas e estado clínico.

24 May 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
RFRenata Rego Lins Fumis
Renata Rego Lins Fumis
ECEduardo Leite Vieira Costa
Eduardo Leite Vieira Costa
BTBruno Martins Tomazini
Bruno Martins Tomazini
LTLeandro Utino Taniguchi
Leandro Utino Taniguchi
LCLivia do Valle Costa
Livia do Valle Costa
JJJose Mauro Vieira Junior
Jose Mauro Vieira Junior
Objective: COVID-19 has been associated with a significant burden to those who survive the acute phase. We aimed to describe the quality of life and symptoms of anxiety, depression, and posttraumatic stress disorder (PTSD) at 90 days after hospital discharge of COVID-19 patients. Methods: Patients with COVID-19 admitted to a private hospital in the city of Sao Paulo, Brazil, between April of 2020 and April of 2021 were interviewed by telephone at 30 and 90 days after discharge to assess the quality of life and symptoms of depression, anxiety, and PTSD. Results: A total of 2,138 patients were included. The mean age was 58.6 +/- 15.8 years, and the median length of hospital stay was 9.0 (5.015.8) days. Between the two time points, depression increased from 3.1% to 7.2% (p < 0.001), anxiety increased from 3.2% to 6.2% (p < 0.001), and PTSD increased from 2.3% to 5.0% (p < 0.001). At least one physical symptom related to COVID-19 diagnosis persisted in 32% of patients at day 90. Conclusions: Persistence of physical symptoms was high even at 90 days after discharge. Although the prevalence of symptoms of anxiety, depression, and PTSD was low, these symptoms persisted for three months, with a significant increase between the time points. This finding indicates the need to identify at-risk patients so that they can be given an appropriate referral at discharge.